Selective inhibitors of CDK4 and CDK6 for the treatment of advanced or metastatic breast cancer/Abemaciclib 150mg 56 tablets

Price GH¢ 4,227.00
Coupons
More>
Comprehensive Score
5
cumulative comments 0
Goods Guarantee 100% authenticity guarantee
Delivery address China
Ship to
FBM products: 7 days without reason return or exchange False a compensate ten
Spesifications
Quantity
Inventory 100
 
TospinoMall Commitment TospinoMall guarantees the security of your transaction: we will only allocate funds to the seller after the buyer confirms the receipt of the goods!
Special recommendation
Afrilinker
Enter Store
Favorite Stores

Specifications
Abemaciclib 150mg 56 tablets
Indications: CDK4 and CDK6 selective inhibitors for the treatment of advanced or metastatic breast cancer. Mainly used to treat 1) hormone receptor-positive, human epidermal growth factor receptor 2-negative lymph node-positive, high risk of recurrence early breast cancer. 2) hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer.

150mg*56 tablets/box for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.
Indications:
Recommended dose: {For reference only, follow doctor's advice}
The recommended dose is 150 mg, twice a day, in combination with aromatase inhibitors such as letrozole or anastrozole.

Selective inhibitors of CDK4 and CDK6 for the treatment of advanced or metastatic breast cancer/Abemaciclib 150mg 56 tabletsSelective inhibitors of CDK4 and CDK6 for the treatment of advanced or metastatic breast cancer/Abemaciclib 150mg 56 tabletsSelective inhibitors of CDK4 and CDK6 for the treatment of advanced or metastatic breast cancer/Abemaciclib 150mg 56 tablets